Healthcare provider profile · identity verified

Gary S Figiel, M.D.

Psychiatry · ATLANTA, GA · NPI 1265412860

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Memantine Hcl	Memantine Hcl	515	88
Quetiapine Fumarate	Quetiapine Fumarate	366	68
Levothyroxine Sodium	Levothyroxine Sodium	324	63
Donepezil Hcl	Donepezil Hcl	312	49
Atorvastatin Calcium	Atorvastatin Calcium	290	55
Clonazepam	Clonazepam	278	57
Venlafaxine Hcl Er	Venlafaxine Hcl	277	55
Tramadol Hcl	Tramadol Hcl	237	61
Lorazepam	Lorazepam	230	68
Mirtazapine	Mirtazapine	221	37
Amlodipine Besylate	Amlodipine Besylate	196	40
Risperidone	Risperidone	190	35
Lisinopril	Lisinopril	186	29
Escitalopram Oxalate	Escitalopram Oxalate	185	32
Gabapentin	Gabapentin	181	42
Olanzapine	Olanzapine	171	30
Rivastigmine	Rivastigmine	165	33
Eliquis	Apixaban	162	31
Sertraline Hcl	Sertraline Hcl	152	29
Trazodone Hcl	Trazodone Hcl	138	29
Metoprolol Succinate	Metoprolol Succinate	132	30
Losartan Potassium	Losartan Potassium	127	18
Potassium Chloride	Potassium Chloride	117	24
Bupropion Xl	Bupropion Hcl	115	26
Simvastatin	Simvastatin	112	19
Carvedilol	Carvedilol	108	15
Furosemide	Furosemide	103	27
Pantoprazole Sodium	Pantoprazole Sodium	90	22
Alprazolam	Alprazolam	89	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	16
Omeprazole	Omeprazole	80	18
Tamsulosin Hcl	Tamsulosin Hcl	77	13
Aripiprazole	Aripiprazole	76	14
Metoprolol Tartrate	Metoprolol Tartrate	75	18
Clopidogrel	Clopidogrel Bisulfate	72	12
Lithium Carbonate	Lithium Carbonate	71	14
Paroxetine Hcl	Paroxetine Hcl	70	11
Rosuvastatin Calcium	Rosuvastatin Calcium	70	suppressed
Duloxetine Hcl	Duloxetine Hcl	68	17
Memantine Hcl Er	Memantine Hcl	63	12
Citalopram Hbr	Citalopram Hydrobromide	61	11
Montelukast Sodium	Montelukast Sodium	59	suppressed
Metformin Hcl	Metformin Hcl	58	14
Divalproex Sodium	Divalproex Sodium	56	14
Fluticasone Propionate	Fluticasone Propionate	53	16
Famotidine	Famotidine	49	12
Lamotrigine	Lamotrigine	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	47	11
Atenolol	Atenolol	46	suppressed
Buspirone Hcl	Buspirone Hcl	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Myrbetriq	Mirabegron	42	suppressed
Latanoprost	Latanoprost	41	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	40	suppressed
Prednisone	Prednisone	39	17
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	38	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	15
Levetiracetam	Levetiracetam	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	34	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	33	suppressed
Torsemide	Torsemide	33	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	32	suppressed
Meloxicam	Meloxicam	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Nystatin	Nystatin	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Modafinil	Modafinil	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	19
Pregabalin	Pregabalin	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Vraylar	Cariprazine Hcl	24	suppressed
Glipizide	Glipizide	22	suppressed
Letrozole	Letrozole	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Rivastigmine	Rivastigmine Tartrate	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Baclofen	Baclofen	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Lurasidone Hcl	Lurasidone Hcl	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Finasteride	Finasteride	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Primidone	Primidone	15	suppressed
Ramipril	Ramipril	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Clozapine	Clozapine	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Belsomra	Suvorexant	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Estradiol	Estradiol	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Haloperidol	Haloperidol	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lipitor	Atorvastatin Calcium	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error